View drug registration information details.
Items | Registration information |
ID | 508 |
No | 508 |
Brand Name | HERCEPTIN 440 MG |
Ingredients | TRASTUZUMAB 440 MG |
Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
Primary Packaging | VIAL |
Storage | |
Shelf Life | 4 YEARS |
Pack Size | 440 MG/VIAL, 1 VIAL OF ACTIVE INGREDIENT AND 1 VIAL OF SOLVENT |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | METASTATIC BREAST CANCER AS MONOTHERAPY OR IN COMBINATION WITH PACLITAXEL OR DOCETAXEL OR AROMATASE INHIBITOR;- EARLY BREAST CANCER FOLLOWING SURGERY, CHEMOTHERAPY AND RADIOTHERAPY; ADVANCED GASTRIC CANCER IN COMBINATION WITH CAPECITABINE OR INTRAVENOUS 5 FLUOROURACIL AND PLATINUM AGENT. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE CAKE, SLIGHTLY OPALESCENT SOLUTION, COLORLESS AFTER RECONSTITUTION. |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | GENENTECH, INC |
Country | SWITZERLAND |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 06 I 4472/18 |
FDD Registration Date | 25-SEP-2024 |
Expiry Date | 24-SEP-2029 |
Back to drug list
|